UBS Group’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-58,540
| Closed | -$12K | – | 7591 |
|
|
2018
Q3 | $12K | Buy |
58,540
+26,270
| +81% | +$5.39K | ﹤0.01% | 6183 |
|
|
2018
Q2 | $8K | Sell |
32,270
-1,357
| -4% | -$336 | ﹤0.01% | 6382 |
|
|
2018
Q1 | $8K | Buy |
33,627
+12,035
| +56% | +$2.86K | ﹤0.01% | 6167 |
|
|
2017
Q4 | $7K | Sell |
21,592
-22,496
| -51% | -$7.29K | ﹤0.01% | 6304 |
|
|
2017
Q3 | $16K | Buy |
44,088
+43,963
| +35,170% | +$16K | ﹤0.01% | 5727 |
|
|
2017
Q2 | $0 | Hold |
125
| – | – | ﹤0.01% | 7231 |
|
|
2017
Q1 | $0 | Sell |
125
-1,187
| -90% | – | ﹤0.01% | 7186 |
|
|
2016
Q4 | $2K | Buy |
1,312
+652
| +99% | +$994 | ﹤0.01% | 6581 |
|
|
2016
Q3 | $3K | Buy |
660
+394
| +148% | +$1.79K | ﹤0.01% | 6427 |
|
|
2016
Q2 | $2K | Buy |
266
+232
| +682% | +$1.74K | ﹤0.01% | 6583 |
|
|
2016
Q1 | $0 | Sell |
34
-405
| -92% | – | ﹤0.01% | 7295 |
|
|
2015
Q4 | $6K | Buy |
439
+46
| +12% | +$629 | ﹤0.01% | 6305 |
|
|
2015
Q3 | $7K | Buy |
393
+234
| +147% | +$4.17K | ﹤0.01% | 6160 |
|
|
2015
Q2 | $3K | Buy |
159
+125
| +368% | +$2.36K | ﹤0.01% | 6510 |
|
|
2015
Q1 | $1K | Sell |
34
-655
| -95% | -$19.3K | ﹤0.01% | 6615 |
|
|
2014
Q4 | $20K | Buy |
+689
| New | +$20K | ﹤0.01% | 5585 |
|